Glazer Capital LLC’s Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share VHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-65,680
Closed -$14K 721
2021
Q4
$14K Sell
65,680
-11,840
-15% -$3.22K ﹤0.01% 789
2021
Q3
$20K Hold
77,520
﹤0.01% 866
2021
Q2
$27K Buy
+77,520
New +$27.9K ﹤0.01% 881

Other funds holding VHAQ.WS

Glazer Capital LLC's VHAQ.WS Position: Q1 2022 in Review

Glazer Capital LLC sold out of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) in Q1 2022, closing a stake of 65,680 shares — an estimated $14K sold.

Glazer Capital LLC first reported a position in VHAQ.WS in Q2 2021 and held it in 3 quarters. The position peaked at $27K in Q2 2021. 32 funds tracked by Wall St. Rank hold VHAQ.WS as of Q1 2022.

  • Glazer Capital LLC reported no remaining Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position as of Q1 2022 after selling out during the quarter.
  • Glazer Capital LLC sold 65,680 Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share shares in Q1 2022, an estimated $14K.
  • Glazer Capital LLC first reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in Q2 2021 and held it in 3 quarters.
  • Glazer Capital LLC's Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share position peaked at $27K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share as of Q1 2022.

Based on Glazer Capital LLC's 13F filing for Q1 2022, filed 17 May 2022.